Abstract
Background
Infantile hemangioma (IH) is one of the most common tumors in infants. Its pathogenesis is complex and poorly understood. The risk factors of IH have been extensively studied from clinical and epidemiological perspectives in recent years, but the conclusions in the literature reports are inconsistent. To provide a reference for the prevention of hemangioma, we conducted a meta-analysis of the published studies of potential risk factors for IH.
Methods
The Cochrane Library, Ovid, PubMed, and Web of Science databases were searched systematically. Log odds ratios (log ORs), logistic regression standard errors and 95% confidence intervals (CIs) were used to compare the correlation between IH and potential risk factors. Review Manager 5.3.3 was used for the statistical analysis.
Results
Six studies were included and 17 potential risk factors were eventually evaluated. P values < 0.05 were found for female gender (P < 0.01, OR 2.04, 95% CI 1.65–2.51), low birth weight (P < 0.01, OR 4.39, 95% CI 3.05–6.31), multiple gestation (P = 0.01, OR 2.39, 95% CI 1.21–4.71), preterm birth (P = 0.03, OR 2.37, 95% CI 1.07–5.23), progesterone therapy (P < 0.01, OR 2.73, 95% CI 2.12–3.51), and family history (P = 0.01, OR 1.98, 95% CI 1.16–3.38).
Conclusions
This meta-analysis revealed that risk factors, including female gender, low birth weight, multiple gestation, preterm birth, progesterone therapy, and family history may affect the occurrence of IH.
Similar content being viewed by others
References
Anderson KR, Schoch JJ, Lohse CM, Hand JL, Davis DM, Tollefson MM. Increasing incidence of infantile hemangiomas (IH) over the past 35 years: correlation with decreasing gestational age at birth and birth weight. J Am Acad Dermatol. 2016;74:120–6.
Dickison P, Christou E, Wargon O. A prospective study of infantile hemangiomas with a focus on incidence and risk factors. Pediatr Dermatol. 2011;28:663–9.
Kanada KN, Merin MR, Munden A, Friedlander SF. A prospective study of cutaneous findings in newborns in the United States: correlation with race, ethnicity, and gestational status using updated classification and nomenclature. J Pediatr. 2012;161:240–5.
Smith CJF, Friedlander SF, Guma M, Kavanaugh A, Chambers CD. Infantile hemangiomas: an updated review on risk factors, pathogenesis, and treatment. Birth Defects Res. 2017;109:809–15.
Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 20 Oct 2011.
Ioannidis JP, Patsopoulos NA, Evangelou E. Heterogeneity in meta-analyses of genome-wide association investigations. PLoS One. 2007;2:e841.
Berkey CS, Hoaglin DC, Mosteller F, Colditz GA. A random-effects regression model for meta-analysis. Stat Med. 1995;14:395–411.
DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials. 2007;28:105–14.
Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.
Rasul S. Clinical characteristics and risk factors for infantile hemangioma a case control study. Eur J Pediatr Surg. 2014;24:102–12.
Chen XD, Ma G, Chen H, Ye XX, Jin YB, Lin XX. Maternal and perinatal risk factors for infantile hemangioma: a case-control study. Pediatr Dermatol. 2013;30:457–61.
Drolet BA, Swanson EA, Frieden IJ, Hemangioma Investigator Group. Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants. J Pediatr. 2008;153:712–5.
Hoornweg MJ, Smeulders MJ, Ubbink DT, van der Horst CM. The prevalence and risk factors of infantile haemangiomas: a case-control study in the Dutch population. Paediatr Perinat Epidemiol. 2012;26:156–62.
Hunjan MK, Schoch JJ, Anderson KR, Lohse CM, Marnach ML, Hand JL, et al. Prenatal risk factors for infantile hemangioma development. J Investig Dermatol. 2017;137:954–7.
Kim EJ, Park HS, Yoon HS, Cho S. Maternal and perinatal factors of importance for occurrence and severity of infantile haemangioma. Acta Derm Venereol. 2015;95:696–9.
Li J, Chen X, Zhao S, Hu X, Chen C, Ouyang F, et al. Demographic and clinical characteristics and risk factors for infantile hemangioma: a Chinese case-control study. Arch Dermatol. 2011;147:1049–56.
Drolet BA, Frieden IJ. Characteristics of infantile hemangiomas as clues to pathogenesis: does hypoxia connect the dots? Arch Dermatol. 2010;146:1295–9.
Janmohamed SR, Brinkhuizen T, den Hollander JC, Madern GC, de Laat PC, van Steensel MA, et al. Support for the hypoxia theory in the pathogenesis of infantile haemangioma. Clin Exp Dermatol. 2015;40:431–7.
North PE, Waner M, Mizeracki A, Mihm MC Jr. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol. 2000;31:11–22.
North PE, Waner M, Mizeracki A, Mrak RE, Nicholas R, Kincannon J, et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol. 2001;137:559–70.
Leon-Villapalos J, Wolfe K, Kangesu L. GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations. Br J Plast Surg. 2005;58:348–52.
de Jong S, Itinteang T, Withers AH, Davis PF, Tan ST. Does hypoxia play a role in infantile hemangioma? Arch Dermatol Res. 2016;308:219–27.
Ion R, Bernal AL. Smoking and preterm birth. Reprod Sci. 2015;22:918–26.
Kwon EK, Seefeldt M, Drolet BA. Infantile hemangiomas: an update. Am J Clin Dermatol. 2013;14:111–23.
Chang EI, Chang EI, Thangarajah H, Hamou C, Gurtner GC. Hypoxia, hormones, and endothelial progenitor cells in hemangioma. Lymphat Res Biol. 2007;5:237–43.
Castrén E, Salminen P, Vikkula M, Pitkäranta A, Klockars T. Inheritance patterns of infantile hemangioma. Pediatrics. 2016;138:e20161623.
Cheung DS, Warman ML, Mulliken JB. Hemangioma in twins. Ann Plast Surg. 1997;38:269–74.
Funding
This study was supported by Natural Science Foundation of Xinjiang Uygur Autonomous Region (2019D01C128).
Author information
Authors and Affiliations
Contributions
YD conceptualized and designed this study, designed the data collection instruments, collected data, carried out the initial analysis, drafted the initial manuscript, and reviewed and revised the manuscript. JZZ collected data, carried out the initial analyses, and reviewed and revised the manuscript. YD and JZZ contributed equally to this work. SRY, FX, and XJK conceptualized and designed the study, coordinated and supervised data collection and critically reviewed the manuscript for important intellectual content. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Ethical approval
Not needed.
Conflict of interest
The authors declare that they have no competing interests. No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ding, Y., Zhang, JZ., Yu, SR. et al. Risk factors for infantile hemangioma: a meta-analysis. World J Pediatr 16, 377–384 (2020). https://doi.org/10.1007/s12519-019-00327-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12519-019-00327-2